High-intensity ultrasound helps curb prostate
Ablation using high-intensity focused ultrasound can effectively control some types of localized prostate cancer for five years or longer, according to a study by German researchers.
Ablation using high-intensity focused ultrasound can effectively control some types of localized prostate cancer for five years or longer, according to a study by German researchers.
Dr. Andreas Blana and colleagues at the University of Regensburg's St. Josef Hospital evaluated results from 140 patients with early or intermediate localized prostate cancer who underwent treatment across
Europe between 1997 and 2001. Follow-up prostate biopsies were negative in 86.4% of patients who underwent focused ultrasound ablation, with a five-year PSA-related failure-free survival rate of 77%. The overall disease-free rate at five and seven years was 66% and 59%, respectively. Findings were published online Nov. 5 in European Urology.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
